A Revolutionary Approach to Flu Prevention: New Molecules Stop Infection Before It Starts

Scientists at Scripps Research have developed a drug-like molecule that potentially blocks the initial stage of type A influenza infection.
Currently, flu medications work by tackling the virus once it has already infected the body. However, researchers at Scripps Research and the Albert Einstein College of Medicine are taking a proactive approach. They have developed drug-like molecules aimed at preventing influenza infections before they start by blocking the initial stage of the viral infection process.